An urban challenge: Diagnosing and treating latent tuberculosis infection

June 5, 2013 by Helen Dodson
Credit: Shutterstock

(Medical Xpress)—A new study from Yale Schools of Medicine and Public Health reveals the challenges in identifying high-risk people in urban settings, especially foreign-born individuals, who may have latent tuberculosis infection (LTBI). The study appears in the Journal of Community Health.

According to the Centers for Disease Control, foreign-born individuals contributed to 62.5% of all new active TB infections in the U.S in 2011, but screening policies and programs are inconsistent for refugees and naturalizing citizens and do not address high-risk undocumented populations.

The method of directly observed therapy (DOT) has been the standard for diagnosing and treating active . But employing the method to find LTBI in inner-city populations, particularly among the foreign-born, has been challenging and largely understudied.

The researchers analyzed data gathered between 2003 and 2011 from a comprehensive mobile healthcare clinic in New Haven, Connecticut. They looked at more than 2500 tuberculin skin tests, and found 356 new LTBIs.

Furthermore, the van reached many people in not generally reached by traditional methods. For example, were among the highest numbers of those being screened and treated, as were those—documented and not—who were born in a country ranked among the highest in tuberculosis prevalence.

"While the Act is likely to increase access to health care and provide insurance to people who are here legally, foreign-born persons here illegally will fail to interact with traditional healthcare systems and will not be detected and treated unless innovative services specifically target this population," according to senior author Frederick L. Altice, M.D., professor of medicine, section of infectious diseases at Yale School of Medicine.

"Foreign-born individuals needing tuberculosis screening services were largely shown to be employed within the community with relatively lower drug use and incarceration rates; this is a great opportunity to show our local and national policymakers that our new immigrants are productive drivers of our economy and need more attention to ensure that they remain in good health," according to first author Jamie Morano, M.D., of the infectious diseases section at Yale School of Medicine.

Explore further: Twin epidemics: HIV and Hepatitis C in the urban Northeast

Related Stories

Twin epidemics: HIV and Hepatitis C in the urban Northeast

May 17, 2013

A new Yale study looks at the scope and consequences of a burgeoning health problem in the cities of the U.S. Northeast: concurrent infection with both HIV and Hepatitis C (HCV). The study appears online in the May 14 issue ...

Tuberculosis in US hits record low

March 21, 2013

Cases of tuberculosis reached an all-time low in the United States last year, but the disease continued to affect minorities at much higher rates than whites, health authorities said Thursday.

Immigration reform needs to address access to health care

March 19, 2013

With comprehensive immigration reform a priority for President Obama and gaining bipartisan and public support, there is a need and an opportunity to consider how the millions of undocumented immigrants should be integrated ...

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.